REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors (Q41410427)
Jump to navigation
Jump to search
scientific article published on 12 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors |
scientific article published on 12 August 2012 |
Statements
1 reference
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors (English)
1 reference
Don G Morris
1 reference
Xiaolan Feng
1 reference
Lisa M DiFrancesco
1 reference
Kevin Fonseca
1 reference
Peter A Forsyth
1 reference
Alexander H Paterson
1 reference
Matt C Coffey
1 reference
Brad Thompson
1 reference
12 August 2012
1 reference
1 reference
31
1 reference
3
1 reference
696-706
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference